Related Experiment Video

Updated: Jun 6, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

[Effect of Shuganlipi decoction on Th1/Th2 cytokines in patients with chronic hepatitis B]

Shi-sheng Jiang1, Shuang-teng He, Yu-ming Han

  • 1Hunan Institute of Traditional Chinese Medicine, Changsha 410006, China.

Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|November 25, 2010
PubMed

Insights

Shuganlipi decoction significantly improved liver function and immune response in chronic hepatitis B (CHB) patients. This traditional Chinese medicine enhances Th1/Th2 cytokine activity, aiding in HBV clearance.

Area of Science:

  • Immunology
  • Hepatology
  • Pharmacology

Context:

  • Chronic hepatitis B (CHB) poses a significant global health challenge.
  • Current treatments for CHB have limitations in efficacy and side effect profiles.
  • Understanding the immunomodulatory effects of traditional Chinese medicine (TCM) is crucial for developing novel therapeutic strategies.

Purpose:

  • To evaluate the therapeutic efficacy of Shuganlipi decoction in CHB patients.
  • To investigate the impact of Shuganlipi decoction on Th1/Th2 cytokine profiles.
  • To assess the effects on liver function markers and hepatitis B virus (HBV) replication.

Summary:

  • A randomized controlled trial involving 86 CHB patients demonstrated that Shuganlipi decoction, when added to conventional therapy, significantly increased the overall treatment response rate compared to the control group (78.13% vs 57.14%).
  • The experimental group showed marked improvements in liver enzymes (ALT, AST) and albumin (ALB) levels.
  • Treatment with Shuganlipi decoction led to a significant shift in cytokine balance, with increased interferon-gamma (IFN-γ) and interleukin-2 (IL-2) and decreased interleukin-6 (IL-6) and interleukin-10 (IL-10).

Impact:

  • Shuganlipi decoction shows potential as an effective adjuvant therapy for CHB.
  • The findings suggest that Shuganlipi decoction modulates the immune response, promoting a Th1-dominant environment conducive to viral clearance.
  • This study provides evidence for the TCM's role in improving liver health and potentially reducing HBV viral load.
Abstract

More Related Videos

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...